<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02355457</url>
  </required_header>
  <id_info>
    <org_study_id>PV4306</org_study_id>
    <nct_id>NCT02355457</nct_id>
  </id_info>
  <brief_title>Biomarkers in Acute Cardiac Care</brief_title>
  <acronym>BACC</acronym>
  <official_title>Biomarkers in Acute Cardiac Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to investigate new cardiac biomarkers and algorithms to
      diagnose acute coronary syndrome in patients with suspected acute myocardial infarction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of the study is to detect and evaluate new cardiac biomarkers, evaluate and
      improve acute coronary syndrome (ACS) risk scores, which takes into account clinical, gender
      specific, psycho-social and lifestyle-risk factors, protein patterns and genetic variability
      in addition to the classical risk factors with respect to the primary endpoint of acute
      myocardial infarction.

      Secondary study aims are :

        -  To provide estimates for the incidence of ACS in patients presenting with recent onset
           chest pain;

        -  To provide accurate, quantifiable measures of precursors of ACS;

        -  DNA, RNA, cells, and serum/plasma for comprehensive genetic, gene expression and
           proteomic studies

        -  To explore the impact of ACS candidate genes on cardiovascular risk stratification by
           using genome-wide analyses and a biological systems approach;

        -  To explore proteins relevant for ACS;

        -  To allow the identification of new therapeutic targets;

        -  To evaluate the impact of socio-economic factors on ACS and CAD risk.

      Patients will be followed up during the hospital stay. Afterwards a telephone follow-up will
      take place after 30 days, 6, 24 and 48 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Years</target_duration>
  <primary_outcome>
    <measure>Acute myocardial infarction as index event</measure>
    <time_frame>Months</time_frame>
    <description>The primary endpoint of the study is acute myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AMI, Mortality, heart failure and quality of life</measure>
    <time_frame>Years</time_frame>
    <description>The secondary endpoint of the study is mortality, heart failure, quality of life.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Chest Pain</condition>
  <arm_group>
    <arm_group_label>Suspected acute myocardial infarction</arm_group_label>
    <description>Patients with recent onset symptoms suggesting acute myocardial infarction</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples, white blood cells.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients presenting with suspected myocardial infarction in the emergency department or
        the chest pain unit of the University Hospital Hamburg-Eppendorf.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptoms suggestive of acute myocardial infarction

          -  Ability to provide written informed consent in accordance with Good epidemiological
             Practice and local legislation

          -  Individuals at least 18 years old

        Exclusion Criteria:

        - Insufficient knowledge of the German language (able to understand and write the German
        language)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Westermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan Blankenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHZ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johannes T Neumann, MD</last_name>
    <phone>0049407410</phone>
    <phone_ext>56800</phone_ext>
    <email>j.neumann@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dirk Westermann, MD</last_name>
    <phone>0049407410</phone>
    <phone_ext>56800</phone_ext>
    <email>d.westermann@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of General and Interventional Cardiology, University Heart Center Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahir Karakas, MD</last_name>
      <phone>0049407410</phone>
      <phone_ext>57975</phone_ext>
      <email>m.karakas@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Neumann JT, Sörensen NA, Schwemer T, Ojeda F, Bourry R, Sciacca V, Schaefer S, Waldeyer C, Sinning C, Renné T, Than M, Parsonage W, Wildi K, Makarova N, Schnabel RB, Landmesser U, Mueller C, Cullen L, Greenslade J, Zeller T, Blankenberg S, Karakas M, Westermann D. Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. JAMA Cardiol. 2016 Jul 1;1(4):397-404. doi: 10.1001/jamacardio.2016.0695.</citation>
    <PMID>27438315</PMID>
  </results_reference>
  <results_reference>
    <citation>Neumann JT, Sörensen NA, Ojeda F, Schwemer T, Lehmacher J, Gönner S, Jarsetz N, Keller T, Schaefer S, Renné T, Landmesser U, Clemmensen P, Makarova N, Schnabel RB, Zeller T, Karakas M, Pickering JW, Than M, Parsonage W, Greenslade J, Cullen L, Westermann D, Blankenberg S. Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I. Clin Chem. 2017 Jan;63(1):394-402. doi: 10.1373/clinchem.2016.262659. Epub 2016 Nov 30.</citation>
    <PMID>27903616</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2015</study_first_submitted>
  <study_first_submitted_qc>January 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2015</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>PD Dr. Dirk Westermann</investigator_full_name>
    <investigator_title>Senior Physician at the Department for General and Interventional Cardiology</investigator_title>
  </responsible_party>
  <keyword>troponin</keyword>
  <keyword>myocardial infarction</keyword>
  <keyword>acs</keyword>
  <keyword>AMI</keyword>
  <keyword>biomarker</keyword>
  <keyword>BACC</keyword>
  <keyword>high-sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

